Monarch Capital Management Has Increased By $994,994 Its Gilead Sciences (GILD) Stake, Price T Rowe Associates Raised Its Five9 (FIVN) Holding

June 19, 2017 - By Kurt Siggers

Monarch Capital Management Inc increased Gilead Sciences (GILD) stake by 58.23% reported in 2016Q4 SEC filing. Monarch Capital Management Inc acquired 14,014 shares as Gilead Sciences (GILD)’s stock declined 8.05%. The Monarch Capital Management Inc holds 38,079 shares with $2.73 million value, up from 24,065 last quarter. Gilead Sciences now has $82.90B valuation. The stock decreased 1.06% or $0.69 during the last trading session, reaching $64.12. About 804 shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has declined 21.80% since June 19, 2016 and is downtrending. It has underperformed by 38.50% the S&P500.

Price T Rowe Associates Inc increased Five9 Inc (FIVN) stake by 1.29% reported in 2016Q4 SEC filing. Price T Rowe Associates Inc acquired 63,275 shares as Five9 Inc (FIVN)’s stock rose 30.16%. The Price T Rowe Associates Inc holds 4.96 million shares with $70.45 million value, up from 4.90M last quarter. Five9 Inc now has $1.31B valuation. The stock increased 4.38% or $0.97 on June 16, reaching $23.1. About shares traded. Five9 Inc (NASDAQ:FIVN) has risen 123.16% since June 19, 2016 and is uptrending. It has outperformed by 106.46% the S&P500.

Among 9 analysts covering Five9 Inc (NASDAQ:FIVN), 7 have Buy rating, 1 Sell and 1 Hold. Therefore 78% are positive. Five9 Inc had 12 analyst reports since October 9, 2015 according to SRatingsIntel. The stock of Five9 Inc (NASDAQ:FIVN) has “Overweight” rating given on Thursday, August 4 by Barclays Capital. The firm has “Buy” rating given on Thursday, June 9 by Craig Hallum. Northland Capital initiated the shares of FIVN in report on Monday, January 4 with “Outperform” rating. The firm earned “Buy” rating on Monday, May 16 by Needham. The firm earned “Buy” rating on Wednesday, November 2 by Needham. The rating was upgraded by Pacific Crest on Friday, March 17 to “Overweight”. Canaccord Genuity maintained the shares of FIVN in report on Thursday, December 3 with “Buy” rating. The stock of Five9 Inc (NASDAQ:FIVN) has “Buy” rating given on Thursday, April 14 by Roth Capital. Bank of America downgraded the stock to “Underperform” rating in Tuesday, September 20 report. As per Wednesday, January 6, the company rating was maintained by Barclays Capital.

Price T Rowe Associates Inc decreased Analogic Corp (NASDAQ:ALOG) stake by 268,830 shares to 540,577 valued at $44.84 million in 2016Q4. It also reduced Hca Holdings Inc (NYSE:HCA) stake by 2.75 million shares and now owns 8.29M shares. Triumph Group Inc New (NYSE:TGI) was reduced too.

Among 27 analysts covering Gilead Sciences (NASDAQ:GILD), 18 have Buy rating, 0 Sell and 9 Hold. Therefore 67% are positive. Gilead Sciences had 65 analyst reports since July 29, 2015 according to SRatingsIntel. The firm has “Buy” rating by Standpoint Research given on Wednesday, February 3. The stock has “Neutral” rating by Citigroup on Wednesday, February 8. As per Monday, November 14, the company rating was initiated by Stifel Nicolaus. The firm has “Buy” rating by Cowen & Co given on Monday, September 21. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) has “Buy” rating given on Wednesday, October 5 by Jefferies. Morgan Stanley maintained the shares of GILD in report on Thursday, May 26 with “Equal-Weight” rating. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) has “Hold” rating given on Wednesday, August 31 by Jefferies. Maxim Group downgraded Gilead Sciences, Inc. (NASDAQ:GILD) on Friday, April 29 to “Hold” rating. The stock has “Outperform” rating by RBC Capital Markets on Monday, October 3. The rating was maintained by RBC Capital Markets with “Outperform” on Wednesday, November 2.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: